News & Updates

Show Multimedia Only

CheckMate 648: Nivo + chemo and nivo + ipi continue to improve OS vs chemo in ESCC at 29-month follow-up

28 May 2024 by

After 29 months of minimum follow‐up, nivolumab plus chemotherapy and nivolumab plus ipilimumab continued to demonstrate clinically meaningful overall survival (OS) benefit vs chemotherapy in patients with previously untreated, unresectable, advanced, recurrent, or metastatic oesophageal squamous-cell carcinoma (ESCC), according to results of the global, open-label, phase III CheckMate 648 trial.

CheckMate 648: Nivo + chemo and nivo + ipi continue to improve OS vs chemo in ESCC at 29-month follow-up

28 May 2024

Bariatric surgery cuts breast cancer risk in women with obesity

25 May 2024

Bariatric surgery appears to have a protective effect on the risk of breast cancer in women with obesity, especially those with hyperinsulinemia, according to data from the Swedish Obese Subjects (SOS) study.

Bariatric surgery cuts breast cancer risk in women with obesity

25 May 2024

Limit intake of ultra-processed food to prolong life: study

24 May 2024 by

Individuals who regularly eat ultra-processed foods are at greater risk of death, which is driven by causes other than cancer and cardiovascular diseases (CVD), reports a study.

Limit intake of ultra-processed food to prolong life: study

24 May 2024

Prophylactic intranasal IFN-α cuts COVID-19 incidence in cancer patients

20 May 2024 by

Prophylactic interferon-alpha (IFN-α) administered intranasally slashed the incidence of COVID-19 by almost half in a cohort of cancer patients in the C-SMART study.

Prophylactic intranasal IFN-α cuts COVID-19 incidence in cancer patients

20 May 2024

Onvansertib plus chemo shows promise in KRAS-mutant metastatic colorectal cancer

20 May 2024

In the second-line treatment of patients with metastatic colorectal cancer harbouring KRAS mutation, onvansertib combined with FOLIFRI/bevacizumab demonstrates promising clinical activity while having a manageable safety profile, according to the results of a phase Ib study.

Onvansertib plus chemo shows promise in KRAS-mutant metastatic colorectal cancer

20 May 2024

Aspirin may offer protection against GI cancer-related death in H pylori-free individuals

18 May 2024

For people who have successfully undergone Helicobacter pylori-eradication therapy, the use of aspirin does more good than harm, such that the benefit of reduced gastrointestinal (GI) cancer-related mortality outweighs the risk of bleeding-related mortality, according to a study.

Aspirin may offer protection against GI cancer-related death in H pylori-free individuals

18 May 2024

Menopausal hormone therapy may protect against gastric cancer in Asians

16 May 2024 by

The use of menopausal hormone therapy among postmenopausal Asian women has been linked to a reduced risk of gastric cancer in a study.

Menopausal hormone therapy may protect against gastric cancer in Asians

16 May 2024

Many female lung cancer patients left out by screening criteria: study

16 May 2024 by

The National Lung Screening Trial (NLST) in Singapore falls short of identifying some individuals, particularly women, who are at an increased risk of developing lung cancer, according to a study. However, those who meet the criteria may derive significant benefits from the screening.

Many female lung cancer patients left out by screening criteria: study

16 May 2024

Diabetes spells increased cancer risk

15 May 2024

People with diabetes are at heightened risk of cancer, with the risk starting to increase even before the diagnosis of diabetes and peaking in the year after, according to a study.

Diabetes spells increased cancer risk

15 May 2024

More frequent colonoscopy surveillance not needed for early-onset colorectal cancer

15 May 2024

Early-onset colorectal cancer (CRC) does not appear to carry an increased risk of advanced neoplasia compared with average-onset CRC and, hence, does not require more frequent colonoscopy surveillance, according to a study.

More frequent colonoscopy surveillance not needed for early-onset colorectal cancer

15 May 2024

News & Updates

Showing Oncology articles

Showing

Specialty:

CheckMate 648: Nivo + chemo and nivo + ipi continue to improve OS vs chemo in ESCC at 29-month follow-up

CheckMate 648: Nivo + chemo and nivo + ipi continue to improve OS vs chemo in ESCC at 29-month follow-up

Bariatric surgery cuts breast cancer risk in women with obesity

Bariatric surgery cuts breast cancer risk in women with obesity

Limit intake of ultra-processed food to prolong life: study

Limit intake of ultra-processed food to prolong life: study

Prophylactic intranasal IFN-α cuts COVID-19 incidence in cancer patients

Prophylactic intranasal IFN-α cuts COVID-19 incidence in cancer patients

Onvansertib plus chemo shows promise in KRAS-mutant metastatic colorectal cancer

Onvansertib plus chemo shows promise in KRAS-mutant metastatic colorectal cancer

Aspirin may offer protection against GI cancer-related death in H pylori-free individuals

Aspirin may offer protection against GI cancer-related death in H pylori-free individuals

Menopausal hormone therapy may protect against gastric cancer in Asians

Menopausal hormone therapy may protect against gastric cancer in Asians

Many female lung cancer patients left out by screening criteria: study

Many female lung cancer patients left out by screening criteria: study

Diabetes spells increased cancer risk

Diabetes spells increased cancer risk

More frequent colonoscopy surveillance not needed for early-onset colorectal cancer

More frequent colonoscopy surveillance not needed for early-onset colorectal cancer